Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
+4.81M
-
Total reported value, excl. options
-
$1.51B
-
Value change
-
+$237M
-
Put/Call ratio
-
0.59
-
Number of buys
-
119
-
Number of sells
-
-104
-
Price
-
$52.93
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q4 2018
256 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q4 2018.
Medpace Holdings, Inc. - Common Stock (MEDP) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 30.9M outstanding shares and own 92.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.16M shares), Vanguard Group Inc (3.12M shares), Pendal Group Ltd (1.59M shares), ACADIAN ASSET MANAGEMENT LLC (1.36M shares), WASATCH ADVISORS INC (1.19M shares), FULLER & THALER ASSET MANAGEMENT, INC. (799K shares), Bank of New York Mellon Corp (753K shares), STATE STREET CORP (746K shares), AMERIPRISE FINANCIAL INC (712K shares), and Voya Investment Management LLC (697K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.